Cargando…

Comparative efficacy of novel antidiabetic drugs on cardiovascular and renal outcomes in patients with diabetic kidney disease: A systematic review and network meta‐analysis

AIMS: To conduct a systematic review and network meta‐analysis to determine the comparative effectiveness of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors, glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and dipeptidyl peptidase‐4 (DPP‐4) inhibitors in patients with diabetic kidney disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Hongwei, Liu, Tao, Wang, Li, Ji, Qiuhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541855/ https://www.ncbi.nlm.nih.gov/pubmed/35665989 http://dx.doi.org/10.1111/dom.14702

Ejemplares similares

Comparative effectiveness of oral antidiabetic drugs in preventing cardiovascular mortality and morbidity: A network meta-analysis
por: Lee, Gyeongsil, et al.
Publicado: (2017)

Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
por: Cheung, BMY, et al.
Publicado: (2020)

Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis
por: Mearns, Elizabeth S., et al.
Publicado: (2015)

Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis
por: Liang, Hui-ling, et al.
Publicado: (2017)

Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis
por: Fei, Yue, et al.
Publicado: (2019)

Comparative effectiveness of incident oral antidiabetic drugs on kidney function
por: Hung, Adriana M, et al.
Publicado: (2012)

Cardiovascular mortality and oral antidiabetic drugs: protocol for a systematic review and network meta-analysis
por: Goyat, Rashmi, et al.
Publicado: (2017)

Efficacy and Cardiovascular Safety of Antidiabetic Medications
por: Pappachan, Joseph M.
Publicado: (2021)

Glycaemic control efficacy of oral antidiabetic drugs in treating type 2 diabetes: a protocol for network meta-analysis
por: Jia, Yongliang, et al.
Publicado: (2015)

Recent cardiovascular outcome trials of antidiabetic drugs: A comparative analysis
por: Singh, Awadhesh Kumar, et al.
Publicado: (2017)

Cardiovascular outcomes and safety with antidiabetic drugs
por: Aldossari, Khaled K.
Publicado: (2018)

Repurposing Antidiabetic Drugs for Cardiovascular Disease
por: Schubert, Mario, et al.
Publicado: (2020)

Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes
por: Wolff, Georg, et al.
Publicado: (2022)

Comparative Efficacy of Novel Antidiabetic Drugs on Albuminuria Outcomes in Type 2 Diabetes: A Systematic Review
por: Liu, Geng, et al.
Publicado: (2023)

Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis
por: Nishimura, Rimei, et al.
Publicado: (2021)

Efficacy and Safety of Oral Antidiabetic Drugs in Comparison to Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis
por: Poolsup, Nalinee, et al.
Publicado: (2014)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Lo, Chris Wai Hang, et al.
Publicado: (2021)

A systematic review comparing the evidence for kidney function outcomes between oral antidiabetic drugs for type 2 diabetes
por: Wilkinson, Samantha V., et al.
Publicado: (2018)

Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications
por: Huri, Hasniza Zaman, et al.
Publicado: (2015)

Efficacy of canagliflozin combined with antidiabetic drugs in treating type 2 diabetes mellitus: Meta‐analysis of randomized control trials
por: Meng, Qi, et al.
Publicado: (2015)

Glomerular filtration rate as a kidney outcome of diabetic kidney disease: a focus on new antidiabetic drugs
por: Kim, Hyo Jin, et al.
Publicado: (2022)

Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections
por: Sun, Bao, et al.
Publicado: (2021)

Beyond Blood Sugar: Investigating the Cardiovascular Effects of Antidiabetic Drugs
por: Ahmad, Binish A, et al.
Publicado: (2023)

Comparison of antidiabetic drugs added to sulfonylurea monotherapy in patients with type 2 diabetes mellitus: A network meta-analysis
por: Qian, Dan, et al.
Publicado: (2018)

Effects of Antidiabetic Drugs on Endothelial Function in Patients With Type 2 Diabetes Mellitus: A Bayesian Network Meta-Analysis
por: Wang, Yuhan, et al.
Publicado: (2022)

Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications
por: Huri, Hasniza Zaman, et al.
Publicado: (2015)

Comparison of non-insulin antidiabetic agents as an add-on drug to insulin therapy in type 2 diabetes: a network meta-analysis
por: Yoon, Jeong-Hwa, et al.
Publicado: (2018)

Effects of oral antidiabetic drugs on left ventricular mass in patients with type 2 diabetes mellitus: a network meta-analysis
por: Ida, Satoshi, et al.
Publicado: (2018)

Comparison of Oral Antidiabetic Drugs as Add-On Treatments in Patients with Type 2 Diabetes Uncontrolled on Metformin: A Network Meta-Analysis
por: Qian, Dan, et al.
Publicado: (2018)

Optimizing weight control in diabetes: antidiabetic drug selection
por: Kalra, S, et al.
Publicado: (2010)

Adherence to Oral Antidiabetic Drugs in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis
por: Piragine, Eugenia, et al.
Publicado: (2023)

A variant of PSMD6 is associated with the therapeutic efficacy of oral antidiabetic drugs in Chinese type 2 diabetes patients
por: Chen, Miao, et al.
Publicado: (2015)

Dietary Intake as a Link between Obesity, Systemic Inflammation, and the Assumption of Multiple Cardiovascular and Antidiabetic Drugs in Renal Transplant Recipients
por: Guida, Bruna, et al.
Publicado: (2013)

Comparison the effects of finerenone and SGLT2i on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus: A network meta-analysis
por: Li, Xuefeng, et al.
Publicado: (2022)

Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis
por: Zhang, Da-Peng, et al.
Publicado: (2020)

Effects of first‐line antidiabetic drugs on the improvement of arterial stiffness: A Bayesian network meta‐analysis
por: Wang, Jincheng, et al.
Publicado: (2023)

Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs
por: Hirshberg, Boaz, et al.
Publicado: (2011)

Antidiabetic Drug Prescription Pattern in Hospitalized Older Patients with Diabetes
por: Ardoino, Ilaria, et al.
Publicado: (2023)

Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma
por: Zhou, Yao-Yao, et al.
Publicado: (2016)

Antidiabetic Drug Efficacy in Reduction of Mortality during the COVID-19 Pandemic
por: Gonikman, Daniel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_amqbbfk43ra9kq9qi1156kmcka